Author’s honoraria from opioid seller

I am disturbed that Canadian Family Physician published the article “New category of opioid-related death” by Dr Gallagher in the February issue.¹ I do not know Dr Gallagher, but an article touting the benefits of treating noncancer pain with opioids in the elderly by someone who has received honoraria from Purdue Pharma, a big seller of opioids, strikes me as not too far from the key opinion leader articles that encouraged the opioid crisis in the first place. At the very least we should be aware of the size of the honoraria before deciding on the value of the piece.